Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression

Abstract

The human dopamine transporter (DAT1) gene contains a variable number of tandem repeats (VNTR) in its 3′-untranslated region (UTR). The linkage and association between the VNTR polymorphism of DAT1 and various neuropsychiatric disorders have been reported. We have determined the genomic structure of DAT1 genes containing 7-, 9-, 10-, and 11-repeat alleles and examined the effect of VNTR polymorphism in the 3′-UTR region of DAT1 on gene expression using the luciferase reporter system in COS-7 cells. Luciferase expression was significantly higher when the 3′-UTR of the DAT1 gene contained the 10-repeat allele than when it contained the 7- or 9-repeat alleles. This suggests that VNTR polymorphism affects the expression of the dopamine transporter.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Iversen LL . Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 1971 41: 571–591

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vandenbergh DJ, Persico AM . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs Mol Brain Res 1992 15: 161–166

    Article  CAS  PubMed  Google Scholar 

  3. Amara SG, Kuhar MJ . Neurotransmitter transporters: recent progress Annu Rev Neurosci 1993 16: 73–93

    Article  CAS  PubMed  Google Scholar 

  4. Giros B, Caron MG . Molecular characterization of the dopamine transporter Trends Pharmacol Sci 1993 14: 43–49

    Article  CAS  PubMed  Google Scholar 

  5. Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T et al . Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol 1992 42: 383–390

    CAS  PubMed  Google Scholar 

  6. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996 379: 606–612

    Article  CAS  PubMed  Google Scholar 

  7. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al . Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992 14: 1104–1106

    Article  CAS  PubMed  Google Scholar 

  8. Sano A, Kondoh K, Kakimoto Y, Kondo I . A 40-nucleotide repeat polymorphism in the human dopamine transporter gene Hum Genet 1993 91: 405–406

    Article  CAS  PubMed  Google Scholar 

  9. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al . Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995 56: 993–998

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Le Couteur DG, Leighton PW, McCann SJ, Pond SM . Association of a polymorphism in the dopamine-transporter gene with Parkinson’s disease Mov Disord 1997 12: 760–763

    Article  CAS  PubMed  Google Scholar 

  11. Mercier G, Turpin JC, Lucotte G . Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson’s disease: no association found J Neurol 1999 246: 45–47

    Article  CAS  PubMed  Google Scholar 

  12. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al . Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium Biol Psychiatry 1997 41: 299–304

    Article  CAS  PubMed  Google Scholar 

  13. Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P et al . DAT1 gene polymorphism in alcoholism: a family-based association study Biol Psychiatry 1999 45: 652–654

    Article  CAS  PubMed  Google Scholar 

  14. Muramatsu T, Higuchi S . Dopamine transporter gene polymorphism and alcoholism Biochem Biophys Res Commun 1995 211: 28–32

    Article  CAS  PubMed  Google Scholar 

  15. Blum K, Braverman ER, Wu S, Cull JG, Chen TJ, Gill J et al . Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB) Mol Psychiatry 1997 2: 239–246

    Article  CAS  PubMed  Google Scholar 

  16. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al . Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode Am J Med Genet 1996 67: 406–408

    Article  CAS  PubMed  Google Scholar 

  17. Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B et al . Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association Schizophr Res 1996 20: 175–180

    Article  CAS  PubMed  Google Scholar 

  18. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1531

    Article  CAS  PubMed  Google Scholar 

  19. Joensson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P et al . Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CFS of healthy volunteers Psychiatry Res 1998 79: 1–9

    Article  Google Scholar 

  20. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al . Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22: 133–139

    Article  CAS  PubMed  Google Scholar 

  21. Jacobson LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB et al . Prediction of dopamine transporter binding availability by genotype: a preliminary report Am J Psychiatry 2000 157: 1700–1703

    Article  Google Scholar 

  22. Laine TPJ, Ahonen A, Torniainen P, Heikkila J, Pyhtinen J, Rasanen P et al . Dopamine transporters increase in human brain after alchol withdrawal Mol Psychiatry 1999 4: 189–191

    Article  CAS  PubMed  Google Scholar 

  23. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T et al . Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism Mol Psychiatry 1999 4: 552–557

    Article  CAS  PubMed  Google Scholar 

  24. Koike H, Tomioka S, Sorimachi H, Saido SC, Maruyama K, Okuyama A et al . Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein Biochem J 1999 343: 371–375

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chu G, Hayakawa H, Berg P . Electroporation for the efficient transfection of mammalian cells with DNA Nucl Acid Res 1987 15: 1311–1326

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Ishiura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuke, S., Suo, S., Takahashi, N. et al. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1, 152–156 (2001). https://doi.org/10.1038/sj.tpj.6500026

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500026

Keywords

This article is cited by

Search

Quick links